CorMedix Inc (NYSE American:CRMD)

0.1897
Delayed Data
As of May 25
 +0.0097 / +5.39%
Today’s Change
0.17
Today|||52-Week Range
0.78
-62.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues136.2K61.1K92.5K23.2K
 
 
 
 
 
Cost of Goods Sold18.1K66.7K-63.3K28.6K
 
 
 
 
 
Depreciation And Amortization8.9K9.0K10.2K19.4K
 
 
 
 
 
 
Operating ExpensesGross Income109.2K-14.6K145.6K-24.7K
 
 
 
 
 
General Expenses7.1M8.0M10.4M10.2M
 
 
 
 
 
Research And Development5.1M6.0M8.5M8.3M
 
 
 
 
 
Total Operating Expenses7.2M8.1M10.4M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-8.0M-10.3M-10.2M
 
 
 
 
 
Extraordinary Credit1.9M0.000.000.00
 
 
Extraordinary Charge0.00-2.0M-56.5K0.00
 
 
 
Other Expenses-5.5K-7.5K-5.1K-11.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-10.0M-10.3M-10.2M
 
 
 
 
 
Net Income-5.1M-10.0M-10.3M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.6M60.3M66.7M75.4M
 
 
 
 
 
Shares To Calculate EPS Diluted52.6M60.3M66.7M75.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.17-$0.15-$0.14
 
 
 
 
 
EPS Diluted-$0.10-$0.17-$0.15-$0.14